There were 2,437 press releases posted in the last 24 hours and 440,378 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Atara Biotherapeutics Reports Early Findings of Potential Efficacy from Phase 1 Study of ATA188 in Patients with Progressive Multiple Sclerosis at ECTRIMS 2019

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image